We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$31.8B
AUM Growth
-$7.3B
(-19%)
Cap. Flow
-$363M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
23.56%
Holding
999
New
22
Increased
368
Reduced
528
Closed
49
Avg Time Held
3.4
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$175M |
| 2 |
Banco Santander Chile
BSAC
|
+$99.6M |
| 3 |
Royalty Pharma
RPRX
|
+$54.4M |
| 4 |
Charles Schwab
SCHW
|
+$50.5M |
| 5 |
Darling Ingredients
DAR
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$181M |
| 2 |
NextEra Energy
NEE
|
+$167M |
| 3 |
Huntington Bancshares
HBAN
|
+$166M |
| 4 |
AbbVie
ABBV
|
+$88.9M |
| 5 |
PayPal
PYPL
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Infosys
INFY
$48.8B
| $4.33M | 0.01% |
234,597
-90,529
| -28% | -$1.8M |
2017 Q3
19 quarters
|
|
577
Jack Henry & Associates
JKHY
$10.7B
| $4.31M | 0.01% |
23,631
-635
| -3% | -$119K |
2018 Q2
16 quarters
|
|
578
Synchrony
SYF
$24.2B
| $4.26M | 0.01% |
152,676
+14,037
| +10% | +$487K |
2017 Q3
19 quarters
|
|
579
DELISTED
Marathon Oil Corporation
MRO
| $4.25M | 0.01% |
187,321
+8,284
| +5% | +$222K |
2017 Q3
19 quarters
|
|
580
Viatris
VTRS
$21.2B
| $4.23M | 0.01% |
403,710
-5,985
| -1% | -$65.6K |
2017 Q3
19 quarters
|
|
581
Monolithic Power Systems
MPWR
$60.2B
| $4.23M | 0.01% |
10,855
-1,071
| -9% | -$452K |
2020 Q4
6 quarters
|
|
582
Conagra Brands
CAG
$6.84B
| $4.19M | 0.01% |
121,708
-3,709
| -3% | -$126K |
2017 Q3
19 quarters
|
|
583
Paycom
PAYC
$11.2B
| $4.19M | 0.01% |
14,903
+357
| +2% | +$105K |
2019 Q2
12 quarters
|
|
584
PTC
PTC
$21B
| $4.17M | 0.01% |
39,014
+2,618
| +7% | +$283K |
2018 Q4
14 quarters
|
|
585
Dover
DOV
$26.4B
| $4.17M | 0.01% |
34,388
-8,466
| -20% | -$1.14M |
2017 Q3
19 quarters
|
|
586
XPeng
XPEV
$8.97B
| $4.14M | 0.01% |
129,057
+74,883
| +138% | +$1.93M |
2020 Q4
6 quarters
|
|
587
Expedia Group
EXPE
$34.4B
| $4.12M | 0.01% |
43,844
+2,762
| +7% | +$391K |
2017 Q3
19 quarters
|
|
588
Vistra
VST
$51.6B
| $4.11M | 0.01% |
179,569
-29,888
| -14% | -$739K |
2018 Q1
17 quarters
|
|
589
Block Inc
XYZ
$46.8B
| $4.07M | 0.01% |
66,003
+4,808
| +8% | +$439K |
2018 Q2
16 quarters
|
|
590
Ingersoll Rand
IR
$30.2B
| $4.06M | 0.01% |
95,796
-5,149
| -5% | -$234K |
2020 Q1
9 quarters
|
|
591
Teradyne
TER
$52.4B
| $4.05M | 0.01% |
44,616
+2,120
| +5% | +$221K |
2019 Q4
10 quarters
|
|
592
Vail Resorts
MTN
$5.38B
| $4.03M | 0.01% |
18,008
+3,913
| +28% | +$957K |
2018 Q2
16 quarters
|
|
593
Corpay
CPAY
$26B
| $4.02M | 0.01% |
19,077
-863
| -4% | -$206K |
2017 Q3
19 quarters
|
|
594
Citizens Financial Group
CFG
$26.6B
| $4.02M | 0.01% |
112,069
+4,437
| +4% | +$175K |
2017 Q3
19 quarters
|
|
595
BJs Wholesale Club
BJ
$12.8B
| $3.96M | 0.01% |
63,002
-301,266
| -83% | -$18.9M |
2018 Q4
14 quarters
|
|
596
Ares Capital
ARCC
$13.5B
| $3.95M | 0.01% |
219,424
+64,816
| +42% | +$1.28M |
2022 Q1
1 quarter
|
|
|
TDCX
597
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $3.95M | 0.01% |
425,167
| – | – |
2021 Q4
2 quarters
|
|
598
Seagate
STX
$149B
| $3.95M | 0.01% |
55,294
-3,357
| -6% | -$273K |
2021 Q3
3 quarters
|
|
599
IDEX
IEX
$17.4B
| $3.94M | 0.01% |
21,763
+752
| +4% | +$142K |
2018 Q2
16 quarters
|
|
600
AbCellera Biologics
ABCL
$3.86B
| $3.92M | 0.01% |
375,062
-35,390
| -9% | -$300K |
2021 Q1
5 quarters
|
|
Similar funds
Aberdeen Group's Q2 2022 Portfolio in Review
As of Q2 2022, Aberdeen Group held 999 positions worth $31.8B, down 19% from $39.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group's Q2 2022 filing shows 22 new, 368 increased, 528 reduced and 49 closed positions. Its largest new stake was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M. The largest sale was Meta Platforms (Facebook), an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q2 2022 buy was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M.
- Aberdeen Group added most to Merck in Q2 2022, an estimated $175M increase.
- Aberdeen Group's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $181M.
- Aberdeen Group fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2022, selling an estimated $46.5M.
- Aberdeen Group's ten largest holdings make up 24% of its $31.8B portfolio in Q2 2022.
- Aberdeen Group opened 22 new positions and closed 49 in Q2 2022.
- Aberdeen Group's portfolio value fell 19% quarter-over-quarter to $31.8B.
Based on Aberdeen Group's 13F filing for Q2 2022, filed 5 Aug 2022.